Turmeric and Curcumin: What Studies Found, and the Liver Safety Reports

By The Kasivit Editorial Team · Library · October 2026

Turmeric is the bright yellow spice behind many curries, and curcumin is the compound in it that researchers have studied most.^1,3 Turmeric and curcumin supplements are now widely sold for joint comfort. This article looks at what the arthritis trials reported, why curcumin is hard for the body to absorb, and what a US network that tracks liver injury found when it reviewed cases linked to turmeric products.

General information, not medical advice.

Turmeric and curcumin are not the same thing

Turmeric is the dried root of the Curcuma longa plant. A 2022 review describes its main chemical components as curcumin and turmeric volatile oil.¹ Supplements vary a great deal: some contain plain turmeric root powder, some contain an extract concentrated in curcumin and related compounds called curcuminoids, and many combine both. Some also add black pepper extract or use special formulations meant to raise absorption. This matters, because a study of one form does not automatically apply to another.

What the arthritis trials found

The 2022 systematic review

Zeng and colleagues pooled 29 randomized controlled trials with 2,396 participants across 5 types of arthritis: ankylosing spondylitis, rheumatoid arthritis, osteoarthritis, juvenile idiopathic arthritis, and gout or high uric acid. Doses of curcumin or turmeric extract ranged from 120 mg to 1,500 mg, given for 4 to 36 weeks. In general, the authors reported that the products appeared safe in these trials and that measures of inflammation and pain improved.¹

The authors were careful in how they framed this. Their conclusion was that curcumin and turmeric extract may improve symptoms and inflammation in people with arthritis, but that because the trials were few and low in quality, the conclusions need to be read carefully. They also called for more trials.¹ In the full text they note that the included trials were at high risk of bias and that some trial authors were funded by manufacturers or were company employees.

A closer look at one knee osteoarthritis trial

Pooled reviews can hide the details, so it helps to look at a single trial. In a randomized, double-blind, placebo-controlled trial from Tasmania, Australia, 70 people with painful knee osteoarthritis and fluid-related swelling in the knee took 2 capsules a day of a Curcuma longa extract (36 people) or a matching placebo (34 people) for 12 weeks.²

On a visual pain scale, the extract group's knee pain fell by 9.1 mm more than the placebo group's (95% CI −17.8 to −0.4 mm; P = 0.039). A second pain questionnaire, the WOMAC knee pain score, also favored the extract (−47.2 mm; 95% CI −81.2 to −13.2 mm; P = 0.006). However, the extract did not change the volume of joint fluid and swelling on MRI (3.2 mL; 95% CI −0.3 to 6.8 mL), which was one of the two main outcomes, and it did not change a measure of cartilage composition.²

Adverse events were reported by 14 people (39%) in the extract group and 18 (53%) in the placebo group (P = 0.16). The authors listed the modest sample size and short duration as limitations and said larger trials at several centers are needed to judge whether the pain difference matters in daily life.²

CI = confidence interval. When the interval for a difference crosses zero, the result is not statistically significant. The upper end of the pain interval in this trial sits close to zero.

Why absorption is a problem

Curcumin taken by mouth reaches the blood poorly. A 2007 review summarized three reasons: poor absorption from the gut, rapid breakdown by the body, and rapid elimination. The same review noted that early-phase human studies found curcumin well tolerated even at high doses of 12 g a day, while blood and tissue levels stayed low.³

The review listed several approaches that researchers have tried to raise absorption: adding piperine from black pepper, which slows one of the body's main routes for breaking curcumin down; packaging curcumin in liposomes or nanoparticles; binding it to phospholipids; and making related synthetic compounds.³ Some of these are now used in commercial supplements, often under trademarked names.

What piperine does

A 1998 study tested piperine with curcumin in rats and in healthy human volunteers. When people took 2 g of curcumin alone, blood levels were undetectable or very low. When the same dose was taken with 20 mg of piperine, blood levels were much higher from 0.25 to 1 hour afterward, and the authors calculated a 2000% increase in bioavailability. They reported no adverse effects at the doses used.⁴

That figure is often repeated, so its limits are worth stating. It came from a small, short pharmacokinetic study that measured blood levels after a single dose, not symptoms or health outcomes. Higher blood levels may also have a downside: the liver injury researchers described below suggested that the growing combination of turmeric with black pepper might help explain the rise in cases they saw.^4,5

Liver injury reports

Turmeric has a long history as a food, and the arthritis trials above reported few safety problems. Even so, liver injury linked to turmeric supplements has been reported. The most detailed US account comes from the Drug-Induced Liver Injury Network (DILIN), a research network that enrolls and studies people with suspected liver injury from medicines and supplements.

The researchers reviewed all cases enrolled between 2004 and 2022 in which a turmeric product was implicated, using a 5-point expert scoring system to judge how likely the product was to be the cause. They found 10 cases, all enrolled since 2011 and 6 of them since 2017. Of the 10 people, 8 were women and 9 were White, and the median age was 56 (range 35 to 71). The injury mainly affected liver cells (hepatocellular) in 9 people and was mixed in 1. Five people were hospitalized, and 1 died of acute liver failure.⁵

The team was able to test 7 of the products: all 7 contained turmeric, and 3 also contained piperine. Genetic testing found that 7 patients carried an immune-system gene variant called HLA-B*35:01, which was far more common in this group than in the general population (allele frequency 0.450, compared with 0.056-0.069 in population controls). Injury typically appeared 1 to 4 months after starting the product.⁵ In the full report, the most common symptoms at presentation were jaundice (yellowing of the skin or eyes), nausea and abdominal pain.

The authors concluded that liver injury from turmeric appears to be increasing in the United States, perhaps because more people are using it or because it is more often combined with black pepper, and that it can be severe.⁵

How to read a case series

A case series describes people who were harmed. It cannot tell us how often harm happens, because nobody counted everyone who took turmeric without a problem. Ten enrolled cases is a small number, but not every case is recognized, reported or enrolled, so the series cannot say how common liver injury is. The cases were real, one was fatal, and the genetic link means a small group of people may be more susceptible without knowing it.⁵

Who paid for these studies?

Funding does not decide whether a study is right, but it is worth knowing, especially when a company that makes the tested ingredient helped pay for the work. This is what we could confirm.

• Zeng 2022 review. We found no funding statement in the published full text. The authors declared no commercial or financial conflicts of interest, and they noted that some of the trials they pooled were run by authors funded by manufacturers or employed by them.¹
• Wang 2020 knee trial. The abstract lists the primary funding sources as the University of Tasmania and Natural Remedies Private Limited, a private company. The full text was not open access, so we could not confirm who supplied the extract and placebo capsules.²
• DILIN liver injury series. Funded by the US National Institute of Diabetes and Digestive and Kidney Diseases as a cooperative agreement, with support from the intramural division of the National Cancer Institute. The authors declared no competing interests.⁵
• Anand 2007 absorption review. PubMed tags this review as having non-US-government research support but does not name the funder, and we could not read the full text.³
• Shoba 1998 piperine study. The PubMed record lists no funder or conflict-of-interest statement, and we could not read the full text, so we cannot say who paid for it or supplied the ingredients.⁴

Limits of the research

• Trial quality. The review authors described the arthritis trials as low in quality and small in number.¹
• Different products. The trials used different forms and doses, from 120 mg to 1,500 mg.¹ A result for one extract does not carry over to a different product or a combination formula.
• Short duration. Trials ran from 4 to 36 weeks, and the knee trial ran 12 weeks.^1,2 They say little about long-term use.
• Effect size. In the knee trial, the pain difference was statistically significant, but the joint fluid and cartilage measures did not change.²
• Absorption data. The piperine study measured blood levels after a single dose, not health outcomes.⁴
• Safety data. Short trials are not designed to catch uncommon harms such as liver injury, and a case series cannot give a rate.
• What was not tested. These studies did not test pregnancy, breastfeeding, children, people with existing liver disease, or turmeric used in cooking.

Food and clinician first

Turmeric in food, in the amounts used for cooking, is part of many traditional diets. Concentrated supplements are a different exposure, especially those designed to raise blood levels. If joint pain is your concern, a clinician can help work out the cause and talk through options, including movement, weight, physical therapy and medicines, before or alongside any supplement.

How to read a turmeric label

The Supplement Facts panel tells you what is in the product, not whether it suits you. The same checks apply to any product, including our Platinum Turmeric, whose label lists black pepper extract (piperine) and shellfish-derived glucosamine.

Turmeric powder versus extract

Look for whether the product contains turmeric root powder, a standardized extract of curcuminoids, or both. Root powder contains much less curcumin by weight than a concentrated extract, so two products with the same milligram figure can contain very different amounts of curcumin.

Absorption enhancers

Check for piperine or black pepper extract, or for formulations described as liposomal, phospholipid-bound or nanoparticle. These are designed to raise blood levels. Given the DILIN authors' concern about black pepper combinations, this is worth knowing before you choose.

Serving size and other products

Every amount is per serving, which may be one capsule or several. Add up turmeric and curcumin from all sources, because it appears in joint formulas, multi-ingredient blends, drinks and some foods.

Other ingredients and allergens

Combination joint formulas often contain other active ingredients such as glucosamine, chondroitin, boswellia or ginger. Check the allergen statement, for example for shellfish, and look at the capsule shell and fillers. Third-party testing marks relate to quality checks on contents, not to health effects.

Safety and who should check first

• Know the warning signs. In the DILIN cases, injury usually appeared 1 to 4 months after starting, and common symptoms included yellowing of the skin or eyes, nausea and abdominal pain.⁵ If you notice symptoms like these while taking any supplement, contact a clinician promptly and bring the product with you.
• Tell your care team. List every supplement you take when you see a clinician or have blood tests, so that a supplement is not missed as a possible cause of a problem.
• Keep supplements away from children. Store all supplements out of reach and sight of children.

The short version

Randomized trials suggest turmeric and curcumin extracts may modestly reduce arthritis pain, but the trials are small, short, and low in quality, and the products vary. Curcumin is poorly absorbed, and piperine sharply raises blood levels in a short study. Liver injury linked to turmeric products has been reported and has sometimes been serious, and US researchers think it may be increasing. Food and a clinician's advice come first, and a label lists contents, not whether a product suits you.